Lazard Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $728K | Buy |
62,554
+32,364
| +107% | +$377K | ﹤0.01% | 1392 |
|
|
2025
Q1 | $222K | Buy |
30,190
+383
| +1% | +$2.82K | ﹤0.01% | 1599 |
|
|
2024
Q4 | $177K | Buy |
+29,807
| New | +$177K | ﹤0.01% | 1641 |
|
|
2024
Q2 | – | Sell |
-175,821
| Closed | -$564K | – | 2208 |
|
|
2024
Q1 | $564K | Sell |
175,821
-15,786
| -8% | -$50.6K | ﹤0.01% | 1031 |
|
|
2023
Q4 | $938K | Sell |
191,607
-7,753
| -4% | -$38K | ﹤0.01% | 967 |
|
|
2023
Q3 | $1.09M | Sell |
199,360
-5,927
| -3% | -$32.3K | ﹤0.01% | 962 |
|
|
2023
Q2 | $1.38M | Sell |
205,287
-198
| -0.1% | -$1.33K | ﹤0.01% | 941 |
|
|
2023
Q1 | $1.81M | Buy |
205,485
+897
| +0.4% | +$7.92K | ﹤0.01% | 927 |
|
|
2022
Q4 | $1.56M | Sell |
204,588
-176,229
| -46% | -$1.35M | ﹤0.01% | 932 |
|
|
2022
Q3 | $2.71M | Buy |
380,817
+19,083
| +5% | +$136K | ﹤0.01% | 821 |
|
|
2022
Q2 | $2.93M | Buy |
361,734
+124,864
| +53% | +$1.01M | ﹤0.01% | 834 |
|
|
2022
Q1 | $3.29M | Sell |
236,870
-1,004,636
| -81% | -$13.9M | ﹤0.01% | 819 |
|
|
2021
Q4 | $34.8M | Buy |
1,241,506
+69,230
| +6% | +$1.94M | 0.04% | 363 |
|
|
2021
Q3 | $39.8M | Buy |
1,172,276
+31,222
| +3% | +$1.06M | 0.05% | 333 |
|
|
2021
Q2 | $46.6M | Buy |
1,141,054
+205,040
| +22% | +$8.38M | 0.05% | 295 |
|
|
2021
Q1 | $37.7M | Buy |
936,014
+363,221
| +63% | +$14.6M | 0.05% | 317 |
|
|
2020
Q4 | $33.9M | Sell |
572,793
-173,453
| -23% | -$10.3M | 0.04% | 329 |
|
|
2020
Q3 | $36.3M | Sell |
746,246
-44,768
| -6% | -$2.18M | 0.05% | 281 |
|
|
2020
Q2 | $38.3M | Buy |
791,014
+44,118
| +6% | +$2.13M | 0.06% | 226 |
|
|
2020
Q1 | $20.7M | Buy |
746,896
+660,346
| +763% | +$18.3M | 0.04% | 306 |
|
|
2019
Q4 | $2.59M | Buy |
+86,550
| New | +$2.59M | ﹤0.01% | 637 |
|